Published in Blood Weekly, July 22nd, 1996
George B. Schreiber, Westat, Inc., Rockville, Maryland, and colleagues used data on 586,507 multiple blood donors to calculate the incidence rates of seroconversion among those individuals whose donations passed all currently used screening tests ("The Risk of Transfusion-Transmitted Viral Infections," the New England Journal of Medicine, June 27, 1996;334:26):1685-1690).
The authors noted that in order to monitor blood supply safety and assess the potential effect of new screening tests, accurate estimates of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.